Sanofi weighs deals above its usual $2–5bn range, with ~€20bn firepower, as Q3 revenue hits €14.4bn and Dupixent patent loss looms in the early 2030s.

Bank of America lowered its Take-Two price target to $330 on reduced EPS estimates, while a reported GTA VI file size drew ...

Nokia holds its 2026 operating profit target but lowers free-cash-flow conversion to 35%-55% and raises restructuring charges to EUR 1.1 billion.

AMD shares fell 4.8% yesterday, caught in a broad semiconductor selloff that had little to do with the chipmaker's own operations. Reuters attributed the weakne ...

LVMH has spent the past week shoring up the physical defences of its most visible Paris addresses while quietly laying the ...

IREN shares climbed 7.0% on Wednesday, lifted by the news that Anthropic had filed for an initial public offering. Reuters ...

Insmed narrowed its Q3 2026 net loss to $100.3 million and lifted the low end of full-year sales guidance for BRINSUPRI and ARIKAYCE; shares rose 17%.

Moderna's INTerpath-001 data showed a 42% cut in melanoma recurrence risk, but Piper Sandler and William Blair split on the ...

SpaceX posted $14.575B Q3 revenue and $4.404B net income, announced a ~$40B lease, and faces a Louisiana lawsuit over ...

Berkshire Hathaway has long been cast as the calm counterweight to skittish technology stocks — a reputation that took on fresh relevance in October, when jitte ...

SanDisk reports fiscal 2027 Q1 results tomorrow. Investors will weigh guidance and long-term contracts against NAND pricing gains and cloud demand risks.

EU-OSHA data shows 37% of EU employees report chronic exhaustion and 29% face work-related stress, as the 19–24 October 2026 ...